Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancers|November 13, 2025
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice?Sonia Morè, Massimo Offidani, Laura Corvatta, et al.
Thrombosis Research|June 30, 2017
High platelet count at diagnosis is a protective factor for thrombosis in patients with essential thrombocythemiaRoberto Latagliata, Marco Montanaro, Michele Cedrone, et al.
Cancers|February 13, 2025
Long-Term Survival with Multiple Myeloma: An Italian ExperienceFrancesca Fazio, Martina Gherardini, Elena Rossi, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2025
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma PatientsSonia Morè, Massimo Offidani, Laura Corvatta, et al.
Vaccines|July 27, 2024
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS StudyAlessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
Leukemia Research|April 25, 2016
Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasmsLuigi Gugliotta, Alessandra Iurlo, Gabriele Gugliotta, et al.
Haematologica|March 19, 2026
A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasoneCarmine Liberatore, Alfonso Piciocchi, Donatella Vincelli, et al.
European Journal of Haematology|January 15, 2026
Imaging in Plasma-Cell Neoplasms: Italian Experts' RecommendationsAlessandro Corso, Monia Marchetti, Monica Galli, et al.
Blood Advances|January 17, 2024
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trialMaria Gabriella Mazzucconi, Francesco Rodeghiero, Giuseppe Avvisati, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2016
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trialsMassimo Gentile, Katja Zirlik, Stefania Ciolli, et al.
Pageof 5